{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:28:35Z","timestamp":1790278115736,"version":"4.1.0"},"reference-count":28,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.3892\/mmr.2014.2041","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T03:02:01Z","timestamp":1394593321000},"page":"2015-2023","source":"Crossref","is-referenced-by-count":36,"title":["Decreased PPAR-\u03b3 expression in the conjunctiva and increased expression of TNF-\u03b1 and IL-1\u03b2 in the conjunctiva and tear fluid of dry eye mice"],"prefix":"10.3892","volume":"9","author":[{"given":"YIHUI","family":"CHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOYAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEIFANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINJIE","family":"SHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"key":"key20180108012503_b1-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"key20180108012503_b2-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"key20180108012503_b3-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPARs: therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"key20180108012503_b4-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"key20180108012503_b5-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/j.1460-2075.1992.tb05072.x","article-title":"The mouse peroxisome proliferator activated receptor recognizes a response element in the 5\u2032 flanking sequence of the rat acyl CoA oxidase gene","volume":"11","author":"Tugwood","year":"1992","journal-title":"EMBO J"},{"issue":"Suppl 3","key":"key20180108012503_b6-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/sj.ijo.0802499","article-title":"Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications","volume":"27","author":"Chinetti","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key20180108012503_b7-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1513\/pats.200501-010AC","article-title":"Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair","volume":"2","author":"Standiford","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"key20180108012503_b8-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10875-007-9074-2","article-title":"The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis","volume":"27","author":"Ramakers","year":"2007","journal-title":"J Clin Immunol"},{"key":"key20180108012503_b9-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"key20180108012503_b10-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/108076803322660495","article-title":"Peroxisome proliferator-activated receptor agonists inhibit interleukin-1beta-mediated nitric oxide production in cultured lacrimal gland acinar cells","volume":"19","author":"Beauregard","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"key":"key20180108012503_b11-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.exer.2004.10.009","article-title":"Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand","volume":"80","author":"Sarayba","year":"2005","journal-title":"Exp Eye Res"},{"key":"key20180108012503_b12-mmr-09-05-2015","first-page":"632","article-title":"A mouse model of keratoconjunctivitis sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20180108012503_b13-mmr-09-05-2015","first-page":"2222","article-title":"Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model","volume":"13","author":"Park","year":"2007","journal-title":"Mol Vis"},{"key":"key20180108012503_b14-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1167\/iovs.02-1319","article-title":"Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca","volume":"44","author":"Song","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20180108012503_b15-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"key20180108012503_b16-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","article-title":"Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"key":"key20180108012503_b17-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20180108012503_b18-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8","article-title":"Peroxisome proliferator - activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes","volume":"44","author":"Fahmi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"key20180108012503_b19-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/MCB.20.13.4699-4707.2000","article-title":"Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene","volume":"20","author":"Li","year":"2000","journal-title":"Mol Cell Biol"},{"key":"key20180108012503_b20-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"32681","DOI":"10.1074\/jbc.M002577200","article-title":"Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B","volume":"275","author":"Chung","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180108012503_b21-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1074\/jbc.M507784200","article-title":"Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function","volume":"281","author":"Gao","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180108012503_b22-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diabetes.51.5.1319","article-title":"Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory","volume":"51","author":"Ruan","year":"2002","journal-title":"Diabetes"},{"key":"key20180108012503_b23-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/endo.140.1.6457","article-title":"c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity","volume":"140","author":"Camp","year":"1999","journal-title":"Endocrinology"},{"key":"key20180108012503_b24-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J Endocrinol"},{"key":"key20180108012503_b25-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"key20180108012503_b26-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0739-7240(01)00117-5","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review","volume":"22","author":"Houseknecht","year":"2002","journal-title":"Domest Anim Endocrinol"},{"key":"key20180108012503_b27-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1074\/jbc.274.13.9116","article-title":"Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo","volume":"274","author":"Xin","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180108012503_b28-mmr-09-05-2015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archopht.119.5.709","article-title":"Response of experimental retinal neovascularization to thiazolidinediones","volume":"119","author":"Murata","year":"2001","journal-title":"Arch Ophthalmol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2041\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T07:21:56Z","timestamp":1565248916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,12]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,3,12]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.3892\/mmr.2014.2041"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2041","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,12]]}}}